Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v11-FR
Language English French
Date Updated 2022-07-30 2022-07-29
Drug Identification Number 02125331 02125331
Brand name HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG
Common or Proper name Hydrochloride Controlled Release Capsules Hydrochloride Controlled Release Capsules
Company Name PURDUE PHARMA PURDUE PHARMA
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 6MG 6MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-06-23 2022-06-23
Actual start date 2022-06-23 2022-06-23
Estimated end date 2022-08-05 2022-08-05
Actual end date 2022-07-29 2022-07-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments